Waer M - Search Results

1

Differentiation induction of human leukemia cells (HL60) by a combination of 1,25-dihydroxyvitamin D3 and retinoic acid (all trans or 9-cis).

Verstuyf A, Mathieu C, Verlinden L, Waer M, Tan BK, Bouillon R. Verstuyf A, et al. Among authors: waer m. J Steroid Biochem Mol Biol. 1995 Jun;53(1-6):431-41. doi: 10.1016/0960-0760(95)00089-i. J Steroid Biochem Mol Biol. 1995. PMID: 7626492

2

Immunomodulatory effects of 1,25-dihydroxyvitamin D3.

Casteels K, Bouillon R, Waer M, Mathieu C. Casteels K, et al. Among authors: waer m. Curr Opin Nephrol Hypertens. 1995 Jul;4(4):313-8. doi: 10.1097/00041552-199507000-00005. Curr Opin Nephrol Hypertens. 1995. PMID: 7552096 Review.

3

Analogs of 1,25-dihydroxyvitamin D3 as dose-reducing agents for classical immunosuppressants.

van Etten E, Branisteanu DD, Verstuyf A, Waer M, Bouillon R, Mathieu C. van Etten E, et al. Among authors: waer m. Transplantation. 2000 May 15;69(9):1932-42. doi: 10.1097/00007890-200005150-00032. Transplantation. 2000. PMID: 10830234

4

Potential role of 1,25(OH)2 vitamin D3 as a dose-reducing agent for cyclosporine and FK 506.

Mathieu C, Bouillon R, Rutgeerts O, Vandeputte M, Waer M. Mathieu C, et al. Among authors: waer m. Transplant Proc. 1994 Dec;26(6):3130. Transplant Proc. 1994. PMID: 7527950 No abstract available.

5

Prevention of type I diabetes in NOD mice by nonhypercalcemic doses of a new structural analog of 1,25-dihydroxyvitamin D3, KH1060.

Mathieu C, Waer M, Casteels K, Laureys J, Bouillon R. Mathieu C, et al. Among authors: waer m. Endocrinology. 1995 Mar;136(3):866-72. doi: 10.1210/endo.136.3.7867594. Endocrinology. 1995. PMID: 7867594

6

Induction of mixed bone marrow chimerism as potential therapy for autoimmune (type I) diabetes: experience in the NOD model.

Mathieu C, Bouillon R, Rutgeerts O, Waer M. Mathieu C, et al. Among authors: waer m. Transplant Proc. 1995 Feb;27(1):640-1. Transplant Proc. 1995. PMID: 7879129 No abstract available.

7

Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3.

Mathieu C, Waer M, Laureys J, Rutgeerts O, Bouillon R. Mathieu C, et al. Among authors: waer m. Diabetologia. 1994 Jun;37(6):552-8. doi: 10.1007/BF00403372. Diabetologia. 1994. PMID: 7926338

8

Activated form of vitamin D [1,25(OH)2D3] and its analogs are dose-reducing agents for cyclosporine in vitro and in vivo.

Mathieu C, Waer M, Laureys J, Rutgeerts O, Bouillon R. Mathieu C, et al. Among authors: waer m. Transplant Proc. 1994 Oct;26(5):3048-9. Transplant Proc. 1994. PMID: 7940957 No abstract available.

9

[Immune modulation by vitamin D analogs in the prevention of autoimmune diseases].

Bouillon R, Verstuyf A, Branisteanu D, Waer M, Mathieu C. Bouillon R, et al. Among authors: waer m. Verh K Acad Geneeskd Belg. 1995;57(5):371-85; discussion 385-7. Verh K Acad Geneeskd Belg. 1995. PMID: 8571669 Dutch.

10

Prevention of type I diabetes by late intervention with nonhypercalcemic analogues of vitamin D3 in combination with cyclosporin A.

Casteels K, Waer M, Bouillon R, Allewaert K, Laureys J, Mathieu C. Casteels K, et al. Among authors: waer m. Transplant Proc. 1996 Dec;28(6):3095. Transplant Proc. 1996. PMID: 8962198 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

262 results

Search Page

Filters